Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
79,029,194
-
Shares change
-
+12,990,834
-
Total reported value, excl. options
-
$3,467,731,111
-
Value change
-
+$578,501,456
-
Put/Call ratio
-
29%
-
Number of buys
-
134
-
Number of sells
-
-62
-
Price
-
$43.88
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2024
218 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q1 2024.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79,029,194 shares
of 88,059,438 outstanding shares and own 90% of the company stock.
Largest 10 shareholders include FMR LLC (10,155,254 shares), BlackRock Inc. (5,965,413 shares), FEDERATED HERMES, INC. (4,856,078 shares), VANGUARD GROUP INC (4,155,757 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,052,500 shares), JANUS HENDERSON GROUP PLC (3,808,450 shares), STATE STREET CORP (3,163,954 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,630,292 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,467,107 shares), and Boxer Capital, LLC (2,202,812 shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.